Management of complications after total shoulder arthroplasty.
Josef K Eichinger, Joseph W Galvin
https://pubmed.ncbi.nlm.nih.gov/25672497Actively Recruiting
Led by University of Alberta · Updated on 2025-05-30
40
Participants Needed
8
Research Sites
N/A
Total Duration
U
University of Alberta
Lead Sponsor
U
University Hospital Foundation
Collaborating Sponsor
Researchers are comparing two surgical procedures for patients aged 65 years and older who have advanced shoulder osteoarthritis (OA). The study aims to determine which surgery, Total Shoulder Arthroplasty (TSA) or Reverse Total Shoulder Arthroplasty (RTSA), leads to better functional outcomes and quality of life with fewer complications within the first year after surgery. This pilot randomized controlled trial will help decide the feasibility of a larger study to further assess these treatments. Participants will be randomly assigned to receive either TSA or RTSA surgery. The RTSA involves attaching a metal humeral component to the glenoid and a shallow glenoid component to the humerus, with surgical planning based on pre-operative CT scans. TSA replaces the arthritic humeral head with a metal component and the glenoid surface with a polyethylene component, also guided by CT-based templating. Both procedures aim to correct glenoid version within 10 degrees of neutral using standard surgical tools. After surgery, participants will have follow-up visits at 6 weeks, 3 months, 6 months, and 12 months. During these visits, researchers will measure shoulder range of motion, strength, and pain, and collect patient-reported quality of life and shoulder function questionnaires. They will also monitor for complications and medication use. The primary outcome is the change in the Western Ontario Osteoarthritis of the Shoulder (WOOS) score over 12 months. Secondary outcomes include re-operations, strength, range of motion, pain, and quality of life changes. The total study duration for each participant is 12 months post-surgery.
CONDITIONS
Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery and immediate recovery period
Participants undergo either Total Shoulder Arthroplasty (TSA) or Reverse Total Shoulder Arthroplasty (RTSA) as per randomization.
1 surgical visit (in-person)
Duration - 12 months post-surgery
Participants attend follow-up visits for assessments of shoulder range of motion, strength, clinical outcomes, and health-related quality of life questionnaires.
Visits at 6 weeks, 3 months, 6 months, and 12 months (in-person)
Total: 8 locations
1
Royal Alexandra Hospital (Orthopaedic Surgical Centre)
Edmonton, Alberta, Canada, T5H 3V9
Actively Recruiting
2
Glen Sather Sports Medicine Clinic (University of Alberta)
Edmonton, Alberta, Canada, T6G 1Z1
Actively Recruiting
3
Kaye Edmonton Clinic
Edmonton, Alberta, Canada, T6G 1Z1
Actively Recruiting
4
Collaborative Orthopaedic Research (CORe), Clinical Sciences Building
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
5
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
6
Grey Nuns Community Hospital
Edmonton, Alberta, Canada, T6L 5X8
Actively Recruiting
7
Sturgeon Community Hospital
St. Albert, Alberta, Canada, T8N 6C4
Actively Recruiting
8
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
Actively Recruiting
A
Ailar Ramadi, PhD
L
Lauren Beaupre, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Josef K Eichinger, Joseph W Galvin
https://pubmed.ncbi.nlm.nih.gov/25672497B Fink, J M Strauss, U Lamla...
https://pubmed.ncbi.nlm.nih.gov/11480090Sunny H Kim, Barton L Wise, Yuqing Zhang...
https://pubmed.ncbi.nlm.nih.gov/22258770Jay Pandya, Tamara Johnson, Adrian K Low
https://pubmed.ncbi.nlm.nih.gov/29290218Molly T Vogt, Eleanor M Simonsick, Tamara B Harris...
https://pubmed.ncbi.nlm.nih.gov/14609687Tom R Norris, Joseph P Iannotti
https://pubmed.ncbi.nlm.nih.gov/11988723M A Wirth, C A Rockwood
https://pubmed.ncbi.nlm.nih.gov/7924048Scott P Stephens, Kevin C Paisley, Jeffrey Jeng...
https://pubmed.ncbi.nlm.nih.gov/25653326Gilles Walch, Allan A Young, Pascal Boileau...
https://pubmed.ncbi.nlm.nih.gov/22258001G Walch, R Badet, A Boulahia...
https://pubmed.ncbi.nlm.nih.gov/10512449